Immunarray: Quanterix, ImmunArray partner on neurodegenerative disease

Quanterix, a company digitizing biomarker analysis to accurately measure change for precision health, has announced it is making a strategic investment in ImmunArray, a molecular diagnostics company advancing the development of novel, multi-marker tests for complex diseases with compelling levels of accuracy. As part of the deal, ImmunArray gains access to Quanterix Simoa technology. Both [...]The post Quanterix, ImmunArray partner on neurodegenerative disease appeared first on CenterWatch News Online.